Molecular biomarkers of epileptogenesis. - Wikidata - wikimedia - TriplyDB

Molecular biomarkers of epileptogenesis.

Molecular biomarkers of epileptogenesis.

http://www.wikidata.org/entity/Q48833684

about

Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation MicroRNAs in the pathophysiology and treatment of status epilepticus Exploratory Metabolomics Profiling in the Kainic Acid Rat Model Reveals Depletion of 25-Hydroxyvitamin D3 during Epileptogenesis.Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin d1.Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions.Effect of baicalin on hippocampal damage in kainic acid-induced epileptic mice.The challenge and promise of anti-epileptic therapy development in animal models.The methylation hypothesis of pharmacoresistance in epilepsy.Molecular biomarkers of epileptogenesis.The Challenge of microRNA as a biomarker of Epilepsy.Hippocampal Proteome of Rats Subjected to the Li-Pilocarpine Epilepsy Model and the Effect of Carisbamate Treatment.In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity.A 2017 review of pharmacotherapy for treating focal epilepsy: where are we now and how will treatment develop?Metabolomics and Precision Medicine in Trauma: The State of the Field.

P2860

Q26823386-B38E0C4B-4E10-49E2-9911-E3D64469AF9F Q27004814-348A414A-FACC-4539-96DF-17B7EA65BE47 Q27318172-20F6E33F-EE7D-48B9-88DE-4B37C42AC505 Q33789438-98866D47-8D25-45A8-BB54-88CAF2F9876A Q35008940-25540DC9-B989-4A1A-AFAB-CB411B59BBBF Q36354351-75E96D61-A15A-492B-BBB7-829E13609E96 Q37204527-468F77F1-5246-4DBE-85F5-A639BEFCC10E Q37214420-73E5ABD7-5DB2-4994-8AB8-49EC40F0AE7F Q38104379-FB9B39B2-47B5-4A17-A2F8-E04162A65C82 Q38190877-0454222D-0D14-4850-B488-9DC236A2DB39 Q39413662-1E9B98D1-90E6-480A-B300-E2C3D4BC96F6 Q42366877-CB4CBCB7-1E47-4B39-BABF-EDB058F0970B Q44258943-7DB7B0B9-2AD0-4124-971F-1B0445B64C85 Q47548600-2ABEA8BE-4651-41FC-98D5-BF3E0EC613EB Q49558460-02C39F11-CF5F-4697-915C-B3C166079595

P2860

Molecular biomarkers of epileptogenesis.

http://www.wikidata.org/entity/Q48833684

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Molecular biomarkers of epileptogenesis.

@en

Molecular biomarkers of epileptogenesis.

@nl

type

label

Molecular biomarkers of epileptogenesis.

@en

Molecular biomarkers of epileptogenesis.

@nl

prefLabel

Molecular biomarkers of epileptogenesis.

@en

Molecular biomarkers of epileptogenesis.

@nl

P1433

Q48833684-01FD19E9-9755-498E-81DA-A46CC61DAC5C

P1476

Q48833684-6F9D1C5A-4C7F-4C41-857F-974D127DB7D0

P2093

Q48833684-0357D853-642A-48F9-926A-756CF8A0BAD3

Q48833684-96E24B23-19C3-4B34-A2AF-274B73D1D9C7

P2860

Q48833684-032ABEB5-00EE-46E6-8F9F-8A2823AC9D71

Q48833684-0BF6D9D6-9CD7-4E3A-AB3A-8810A7EE3DCC

Q48833684-0E7ABB06-C675-4DCF-A134-CEBE53B816B4

Q48833684-113C0849-059E-4BFB-B788-CB4F8419395C

Q48833684-1184AF4C-7A05-4DC4-9A9C-128646C367B7

Q48833684-11F60DDE-697D-4ACB-90A2-38C79880761D

Q48833684-16D67000-8181-4AE5-89A1-835C39A4C8B3

Q48833684-175E1703-B682-4231-A02B-2C3AD8222947

Q48833684-183C4EC0-E853-40FC-933B-3C959BB3961B

Q48833684-26E14EC6-5C1C-4B5F-9ED5-1089E65C985B

P304

Q48833684-95BD325B-0E81-485B-9243-E074F429A182

P31

Q48833684-91D2752A-1602-471B-A5D5-1C353A63EA46

P356

Q48833684-627EDCBB-4D03-4E3E-AF43-9DD58FEF2371

P433

Q48833684-ABD8C984-8DC8-41B9-989A-87A72D4A8606

P478

Q48833684-E3844705-C361-44BA-9DD4-96C27D126D20

P577

Q48833684-95B89E81-F016-4645-8130-B87EF76D2B46

P5875

Q48833684-A1C89DD5-4791-4703-A008-4A23F2A63FD2

P698

Q48833684-525565FC-A788-4554-B9B8-F8C2CFC1B922

P356

P1433

Biomarkers in Medicine

P1476

Molecular biomarkers of epileptogenesis.

@en

P2093

Asla Pitkänen

http://www.w3.org/2001/XMLSchema#string

Katarzyna Lukasiuk

http://www.w3.org/2001/XMLSchema#string

P2860

N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics.

Talin 2 concentrations in cerebrospinal fluid in patients with epilepsy.

αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.

Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures.

Endothelin-1 is increased in cerebrospinal fluid and associated with unfavorable outcomes in children after severe traumatic brain injury.

Proteomic analysis of cerebrospinal fluid from patients with idiopathic temporal lobe epilepsy.

Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids

CSF Bcl-2 and cytochrome C temporal profiles in outcome prediction for adults with severe TBI.

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury

P304

629-633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM.11.67

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51720561

http://www.w3.org/2001/XMLSchema#string

P698

22003911

http://www.w3.org/2001/XMLSchema#string